Sanofi (SNY)
NASDAQ: SNY · Real-Time Price · USD
55.82
+0.91 (1.66%)
At close: Mar 28, 2025, 4:00 PM
57.69
+1.87 (3.35%)
After-hours: Mar 28, 2025, 7:46 PM EDT
Sanofi Revenue
In the year 2024, Sanofi had annual revenue of 44.29B EUR with 7.73% growth. Sanofi had revenue of 11.42B in the quarter ending December 31, 2024.
Revenue (ttm)
44.29B EUR
Revenue Growth
+7.73%
P/S Ratio
2.99
Revenue / Employee
534,352 EUR
Employees
82,878
Market Cap
137.09B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 44.29B | 3.18B | 7.73% |
Dec 31, 2023 | 41.11B | 805.00M | 2.00% |
Dec 31, 2022 | 40.30B | 1.13B | 2.88% |
Dec 31, 2021 | 39.18B | 1.81B | 4.83% |
Dec 31, 2020 | 37.37B | -262.00M | -0.70% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionSNY News
- 11 hours ago - Press Release: Qfitlia approved as the first therapy in the US to treat hemophilia A or B with or without inhibitors - GlobeNewsWire
- 13 hours ago - US FDA approves Sanofi's bleeding disorder therapy - Reuters
- 18 hours ago - AbbVie Vs. Sanofi: Which Is The Better Investment Right Now - Seeking Alpha
- 1 day ago - Press Release: Dupixent approved as the first-ever biologic medicine in Japan for patients with COPD - GlobeNewsWire
- 3 days ago - Press Release: Chlamydia vaccine candidate granted fast track designation by the US FDA - GlobeNewsWire
- 4 days ago - Press Release: Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosis - GlobeNewsWire
- 5 days ago - Press Release: Availability of the Q1 2025 Aide mémoire - GlobeNewsWire
- 9 days ago - Sanofi to acquire Dren Bio's immunology unit - Reuters